Verrica Pharmaceuticals
Filed with the SEC on · accession 0001193125-26-458527
VRCA filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -4.9% by the first close after the filing.
Verrica Pharmaceuticals filed an 8-K furnishing a press release announcing its financial results for the quarter and nine months ended September 30, 2026, along with recent corporate highlights and details of a related conference call.
Close before
$3.91
Nov 11, 2026
First close after
-4.86%
$3.72
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for VRCA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for VRCA?
Click hereVRCA filed a 8-K (SEC filing). Verrica Pharmaceuticals filed an 8-K furnishing a press release announcing its financial results for the quarter and nine months ended September 30, 2026, along with recent corporate highlights and details of a related conference call.
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
VRCA closed at $3.91 before the filing and $3.72 on Nov 12, 2026 (-4.86%).
Get alerts when VRCA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days